Pharmaceuticals Company Reports Positive Results For ED Study

Petros Pharmaceuticals Takes a Leap Towards OTC Approval with Promising STENDRA(R) Study Results.

Disclaimer: This blog article provides an overview based on a press release from Petros Pharmaceuticals and an article from BioSpace regarding the Phase 2 study of STENDRA(R) for over-the-counter (OTC) approval. This content is for informational purposes only and does not constitute medical advice. Decisions about medication should always involve a heal…